Pura Vida Investments, LLC 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Pura Vida Investments, LLC disclosed 8 US equity positions worth $16.4m in its Q3 2025 13F filing. The largest position was BBNX at 34.0% of the reported book, followed by IMDX and CAI. Against the Q2 2025 filing, it opened 0 new positions, added to 3 and reduced 4 among the top 8 holdings.
What did Pura Vida Investments, LLC own in Q3 2025? Top 8 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | BBNX BETA BIONICS INC | Healthcare | 34.0% | $5.6m | 281,250 | 11150% | added |
| 2 | IMDX INSIGHT MOLECULAR DIA INC | 19.2% | $3.1m | 947,134 | 4965% | added | |
| 3 | CAI CARIS LIFE SCIENCES INC | Healthcare | 16.6% | $2.7m | 89,940 | 100% | added |
| 4 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 11.2% | $1.8m | 45,000 | -50% | reduced |
| 5 | NSPR INSPIREMD INC | 6.6% | $1.1m | 450,517 | 0% | held | |
| 6 | OM OUTSET MED INC | 6.1% | $1.0m | 5,000 | -99% | reduced | |
| 7 | MGX METAGENOMI INC | 3.8% | $626.6k | 264,391 | -72% | reduced | |
| 8 | NTRA NATERA INC | Healthcare | 2.5% | $402.4k | 2,500 | -99% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.